Evidence map›Paper›PMID 39735251›Full record

ArticleJournal of skin cancer2024

Predicting

Oleksandr Dudin, Ozar Mintser, Vitalii Gurianov, Nazarii Kobyliak, Dmytro Kaminskyi, Alina Matvieieva, Roman Shabalkov, Artem Mashukov, Oksana Sulaieva

Abstract read
In one paragraph

Article in Journal of skin cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Oleksandr DudinScientific Department, Medical Laboratory CSD, Kyiv, Ukraine.
Ozar MintserDepartment of Informatics, Information Technology and Transdisciplinary Learning, Shupyk National Healthcare University of Ukraine, Kyiv, Ukraine.
Vitalii GurianovDepartment of Health Care Management, Bogomolets National Medical University, Kyiv, Ukraine.ORCID https://orcid.org/0000-0001-8509-6301
Nazarii KobyliakScientific Department, Medical Laboratory CSD, Kyiv, Ukraine.ORCID https://orcid.org/0000-0001-9814-689X
Dmytro KaminskyiScientific Department, Medical Laboratory CSD, Kyiv, Ukraine.
Alina MatvieievaScientific Department, Medical Laboratory CSD, Kyiv, Ukraine.
Roman ShabalkovScientific Department, Medical Laboratory CSD, Kyiv, Ukraine.
Artem MashukovDepartment of Oncology and Radiotherapy, International Humanitarian University, Odesa, Ukraine.
Oksana SulaievaScientific Department, Medical Laboratory CSD, Kyiv, Ukraine.ORCID https://orcid.org/0000-0002-9614-4652

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Point mutations at codon 600 of the BRAF oncogene are the most common alterations in cutaneous melanoma (CM). Assessment of BRAF status allows to personalize patient management, though the affordability of molecular testing is limited in some countries. This study aimed to develop a model for predicting alteration in BRAF based on routinely available clinical and histological data.

Indexed as

BRAF mutationcutaneous melanomamultilayered perceptronpredictive model

Identifiers

PMID39735251
PMCPMC11671645

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.